Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer
CONCLUSION: Even if we demonstrated that the registries contain clinically relevant information necessary to mimic the eligibility criteria of a selected RCT, the survival is shorter for RW patients compared to their control arm counterpart in the RCT.PMID:37801361 | DOI:10.1080/0284186X.2023.2264484
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Siri B ørø Steinar Thoresen Simon Boge Brant Åslaug Helland Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Lung Cancer | Non-Small Cell Lung Cancer | Norway Health | Study